兽用皮肤科药物市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按适应症、动物类型、配销通路、管理途径、地区和竞争细分

2022 年，全球兽用皮肤科药物市场估值为 148.2 亿美元，预计到 2028 年，复合CAGR将达到 5.25%。近年来，全球兽医行业对特殊治疗的需求激增。在这些专业领域中，兽医皮肤病学作为宠物保健的重要组成部分脱颖而出。皮肤病、过敏和其他皮肤病问题影响着很大一部分动物族群，促进了全球兽用皮肤病药物市场的成长。兽医皮肤病学涉及动物皮肤病的诊断和治疗。这些病症的范围从过敏和寄生虫等常见问题到自体免疫疾病和皮肤肿瘤等更严重的问题。全球兽用皮肤病药物市场主要针对狗和猫等伴侣动物，但也延伸到也可能患有皮肤病的牲畜。

市场概况
预测期	2024-2028
2022 年市场规模	148.2亿美元
2028 年市场规模	200.8亿美元
2023-2028 年CAGR	5.25%
成长最快的细分市场	寄生虫感染
最大的市场	北美洲

全球兽用皮肤科药物市场的一个重要动力是世界各地宠物主人数量的不断增加。随着越来越多的人欢迎狗、猫和其他宠物进入家中，对包括皮肤科治疗在内的医疗保健服务的需求也在增长。宠物主人越来越了解他们的动物的健康需求。他们越来越意识到皮肤病健康的重要性，并且更有可能为他们的宠物寻求专门的护理和治疗。兽医行业在诊断和治疗方面取得了技术进步。这包括使用雷射疗法、先进的诊断和微创手术，提供更精确和有效的皮肤病治疗。畜牧业也为兽医皮肤病学市场做出了贡献，因为牛、马和猪等动物的皮肤问题可能导致重大经济损失。农民和牲畜主人正在寻求有效的皮肤病解决方案来维持动物的健康。宠物保险的普及使得宠物主人在经济上更加可行，可以寻求专门的兽医护理，包括皮肤科治疗，而无需自己承担全部费用。兽医皮肤病药物製造商不断扩大其产品范围，开发创新疗法和药物来解决各种皮肤病。产品的多样性正在推动市场成长。

主要市场驱动因素

宠物拥有量的增加正在推动全球兽用皮肤科药物市场

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：全球兽用皮肤科药物市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依适应症（寄生虫感染、过敏感染、其他）
  • 依动物类型（伴侣动物、牲畜）
  • 按配销通路（医院药房、零售、电子商务）
  • 依给药途径（热带、注射、口服）
  • 按地区
  • 按公司划分 (2022)
• 市场地图
  • 按指示
  • 依动物类型
  • 按配销通路
  • 依给药途径
  • 按地区

第 5 章：亚太地区兽用皮肤科药物市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按指示
  • 依动物类型
  • 按配销通路
  • 依给药途径
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 澳洲
  • 日本
  • 韩国

第 6 章：欧洲兽用皮肤科药物市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按指示
  • 依动物类型
  • 按配销通路
  • 依给药途径
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 西班牙
  • 义大利
  • 英国

第 7 章：北美兽医皮肤病药物市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按指示
  • 依动物类型
  • 按配销通路
  • 依给药途径
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第 8 章：南美洲兽医皮肤科药物市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按指示
  • 依动物类型
  • 按配销通路
  • 依给药途径
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 9 章：中东和非洲兽医皮肤科药物市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按指示
  • 依动物类型
  • 按配销通路
  • 依给药途径
  • 按国家/地区
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 10 章：市场动态

• 司机
• 挑战

第 11 章：市场趋势与发展

• 最近的发展
• 产品发布
• 併购

第 12 章：全球兽用皮肤科药物市场：SWOT 分析

第 13 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第14章：竞争格局

• Elanco Animal Health Incorporated
• Ceva Sante Animale
• Vetoquinol
• Merck & Co., Inc.
• Zoetis Inc.
• Virbac
• Bimeda, Inc
• Vivaldis
• Bioiberica SAU
• Boehringer Ingelheim International GmbH

第 15 章：策略建议

第16章调查会社について・免责事项

Global Veterinary Dermatology Drugs Market was valued at USD 14.82 Billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.25% through 2028. The global veterinary industry has witnessed a surge in demand for specialized treatments in recent years. Among these specialized fields, veterinary dermatology stands out as an essential component of pet healthcare. Skin disorders, allergies, and other dermatological issues affect a significant portion of the animal population, prompting the growth of the global veterinary dermatology drugs market. Veterinary dermatology involves the diagnosis and treatment of skin conditions in animals. These conditions can range from common problems like allergies and parasites to more severe issues like autoimmune diseases and skin tumors. The global veterinary dermatology drugs market primarily caters to companion animals such as dogs and cats but also extends to livestock, which can suffer from skin disorders as well.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 14.82 Billion
Market Size 2028	USD 20.08 Billion
CAGR 2023-2028	5.25%
Fastest Growing Segment	Parasitic Infections
Largest Market	North America

A significant driver of the global veterinary dermatology drugs market is the increasing number of pet owners across the world. As more people welcome dogs, cats, and other pets into their homes, the demand for healthcare services, including dermatological treatments, has grown. Pet owners are becoming more informed about their animals' health needs. They are increasingly aware of the significance of dermatological health and are more likely to seek specialized care and treatment for their pets. The veterinary industry has seen technological advancements in diagnostics and treatments. This includes the use of laser therapy, advanced diagnostics, and minimally invasive procedures, which provide more precise and effective dermatological treatments. The livestock sector also contributes to the veterinary dermatology market, as skin issues in animals like cows, horses, and pigs can lead to significant economic losses. Farmers and livestock owners are seeking effective dermatological solutions to maintain the health of their animals. The rise in pet insurance adoption has made it more financially feasible for pet owners to seek specialized veterinary care, including dermatology treatments, without bearing the full cost themselves. Veterinary dermatology drug manufacturers are continually expanding their product range, developing innovative treatments and medications to address a wide range of skin conditions. This diversity in offerings is driving market growth.

Key Market Drivers

Rising Pet Ownership is Driving the Global Veterinary Dermatology Drugs Market

In recent years, pet ownership has experienced an exponential surge worldwide, and with it, the demand for specialized veterinary care. One particular area that has seen significant growth is veterinary dermatology, as more pet owners are becoming aware of the importance of their pets' skin and coat health. As pets are increasingly considered as beloved members of the family, the global veterinary dermatology drugs market is thriving. The bond between humans and their pets has never been stronger. The COVID-19 pandemic led to a significant increase in pet adoption and ownership, as many people sought companionship and comfort during lockdowns. This surge in pet adoption has continued to grow, transcending geographical boundaries. Furthermore, urbanization and changing lifestyles have made pet ownership more accessible and desirable for people of all ages and backgrounds. As pet ownership grows, so does the awareness of the importance of pet healthcare. This awareness extends to dermatological issues, which are among the most common health concerns for pets. Conditions like allergies, infections, parasites, and other skin-related problems can significantly affect a pet's well-being, leading to discomfort, pain, and reduced quality of life.

Veterinary dermatology is a specialized branch of veterinary medicine dedicated to diagnosing, treating, and preventing skin, hair, and nail disorders in animals. Dermatological problems in pets are often overlooked or misdiagnosed, leading to prolonged suffering for the animals and frustration for their owners. A pet's skin and coat play a vital role in maintaining their overall health. A healthy skin barrier protects against infections, regulates body temperature, and plays a crucial role in sensory perception. Dermatological issues can manifest as itching, hair loss, rashes, or even more severe complications if left untreated. This emphasizes the need for proper veterinary care, which has spurred the growth of the veterinary dermatology drugs market.

As pet owners become more informed about dermatological problems in their pets, they are more likely to seek professional advice and treatment. This growing awareness drives demand for dermatological drugs and treatments. Technological advancements in veterinary medicine have resulted in better diagnostic tools and treatment options for dermatological conditions. This has improved the overall quality of care and made pet owners more willing to invest in treatment. With pets becoming integral members of the family, pet owners are willing to go to great lengths to ensure their pets' comfort and well-being. This extends to investing in specialized treatments and medications for dermatological issues. The growth in the pet insurance industry has made it more affordable for pet owners to seek veterinary care, including dermatological treatments, without breaking the bank.

Increasing Incidence of Dermatological Conditions is Driving the Global Veterinary Dermatology Drugs Market

The global veterinary dermatology drugs market is experiencing a notable surge in growth as the incidence of dermatological conditions in pets and animals continues to rise. Pet owners around the world are increasingly recognizing the importance of maintaining the skin and coat health of their beloved companions. This heightened awareness, coupled with advancements in veterinary dermatology treatments, is driving the expansion of the global market for veterinary dermatology drugs. Skin-related issues, such as allergies, infections, and parasites, are common among pets and animals. Dermatological conditions can cause discomfort, distress, and, in severe cases, impact an animal's overall quality of life. This has led to a surge in pet owners seeking veterinary advice and treatments for their animals' skin and coat problems.

The field of veterinary dermatology has seen remarkable advancements over the years. These breakthroughs have not only improved the diagnosis and treatment of dermatological conditions but have also expanded the range of available treatment options. Modern diagnostic tools, including skin cytology, biopsies, and advanced imaging techniques, have improved the accuracy of diagnosing dermatological conditions. This allows veterinarians to provide more targeted and effective treatments. The introduction of innovative drugs and therapies for dermatological conditions has been a significant driver of market growth. Medications, topical creams, shampoos, and immunotherapy options have all seen substantial improvements in recent years. Allergies are a leading cause of dermatological conditions in pets. New treatments, including allergen-specific immunotherapy, have improved the management of allergies in animals. Veterinary dermatology has evolved into a specialized field with more veterinarians focusing on skin and coat issues. Specialized knowledge has resulted in more effective treatments and care.

The global veterinary dermatology drugs market is expanding rapidly due to the increased incidence of dermatological conditions and the willingness of pet owners to seek proper care for their animals. The market is not limited to pharmaceuticals but also encompasses a wide range of products, including shampoos, creams, and dietary supplements designed to improve skin and coat health. Pet owners are becoming increasingly educated about dermatological issues in animals, prompting them to seek veterinary care and treatment options. The availability of cutting-edge diagnostic tools and treatment options is driving market growth, as veterinarians can provide better care for their patients. Companies in the veterinary dermatology sector continue to invest in research and development, leading to innovative treatments and products that cater to the specific needs of different animals. The growth of veterinary clinics, dermatology centres, and specialty hospitals is making it easier for pet owners to access specialized care for their pets.

Key Market Challenges

Regulatory Hurdles

One of the primary challenges in the veterinary dermatology drugs market is the complex and evolving regulatory landscape. Different countries have varying regulations for approving and marketing these drugs, making it challenging for manufacturers to navigate the global market effectively. The need to comply with multiple regulatory bodies can be time-consuming and costly, hampering the development and distribution of these drugs.

Limited Research and Development

Compared to the pharmaceutical industry for humans, the veterinary dermatology drugs sector receives considerably less attention from the research and development (R&D) community. A shortage of investments and resources for developing innovative treatments for animal skin conditions results in limited treatment options. This scarcity hinders the market's potential for growth.

High Development Costs

Developing new veterinary dermatology drugs can be expensive and time-consuming. Companies must invest in extensive research, clinical trials, and regulatory approval processes. These high development costs can make it financially challenging for smaller companies to enter the market and lead to higher prices for consumers.

Competition and Pricing Pressure

The global veterinary dermatology drugs market is highly competitive, with a limited number of large pharmaceutical companies dominating the industry. This competition exerts pricing pressure, often leading to reduced profit margins. While this may be beneficial for consumers, it discourages innovation and can stifle smaller businesses.

Antibiotic Resistance

Antibiotic resistance is a growing concern in both human and veterinary medicine. The overuse and misuse of antibiotics in animals can lead to the development of antibiotic-resistant strains of bacteria. This resistance can render existing treatments ineffective, and the market's challenge is to develop alternative therapies that are both effective and sustainable.

Seasonal Variability

The demand for veterinary dermatology drugs can be influenced by seasonal factors. Allergies, for example, may worsen during specific times of the year, resulting in fluctuating sales. This seasonality poses a challenge for companies in terms of production planning and inventory management.

Pet Owner Compliance

Another challenge faced by the veterinary dermatology drugs market is pet owner compliance. Many treatments require careful administration and regular application, which can be difficult for pet owners to maintain. Poor compliance can reduce the effectiveness of treatments, impacting the market's growth.

Diagnosis and Treatment Complexity

The diagnosis and treatment of dermatological issues in animals can be complex. Identifying the root cause of skin problems often involves multiple tests and sometimes trial-and-error approaches. This complexity can frustrate pet owners and result in longer treatment periods, leading to challenges in the market.

Key Market Trends

Technological Advancements

The global veterinary dermatology drugs market is experiencing significant growth, driven by a combination of factors, with technological advancements taking center stage. As pet ownership continues to rise, so does the demand for specialized veterinary care, including the treatment of dermatological issues. Veterinary dermatology drugs play a pivotal role in addressing skin and coat-related conditions in pets. With the development of cutting-edge technologies and innovative treatment methods, this market is expanding rapidly. One of the key drivers of the veterinary dermatology drugs market is the adoption of advanced diagnostic technologies. Veterinarians now have access to state-of-the-art tools for identifying skin conditions and allergies in animals. Techniques such as digital dermatoscopy, patch testing, and allergen specific IgE testing are becoming commonplace in veterinary dermatology. These technologies allow for accurate and quicker diagnosis, leading to more effective treatment.

In parallel with diagnostic advancements, the pharmaceutical industry is also making remarkable strides in the development of veterinary dermatology drugs. New medications and therapies are being introduced to the market, offering safer and more effective treatment options for pets suffering from dermatological conditions. One significant development is the use of monoclonal antibodies in veterinary dermatology. These targeted therapies can provide relief from allergies, pruritus, and other skin conditions in pets. Additionally, pharmaceutical companies are investing in research to develop more user-friendly and patient-compliant forms of medication, such as oral tablets and sprays. This not only makes treatment easier for pet owners but also increases treatment adherence.

Advancements in technology have allowed veterinarians to provide more personalized treatment plans for their patients. With the help of data analytics and artificial intelligence, they can analyze a pet's medical history, genetics, and environmental factors to develop a treatment plan tailored to the individual's needs. This customized approach to treatment enhances the effectiveness of veterinary dermatology drugs and minimizes the risk of side effects. The rapid growth of telemedicine in the veterinary industry is also contributing to the expansion of the veterinary dermatology drugs market. Pet owners can now access remote consultations with board-certified veterinary dermatologists, providing convenient access to expert advice and diagnoses. This not only saves time but also helps in early diagnosis and treatment of skin conditions in pets. Telemedicine complements traditional in-person veterinary visits and ensures that dermatological issues are addressed promptly. The demand for veterinary dermatology drugs is not limited to any specific region. As pet ownership becomes more widespread across the globe, the market for these specialized drugs is expanding internationally. Emerging markets are experiencing significant growth in this sector, offering new opportunities for pharmaceutical companies and technology providers.

Segmental Insights

Indication Insights

Based on the category of Indication, Parasitic Infections emerged as the dominant player in the global market for Veterinary Dermatology Drugs in 2022. Parasitic infections in animals, especially in companion animals like dogs and cats, are becoming increasingly prevalent. These infections can range from common flea infestations to more severe conditions like sarcoptic mange and ear mites. The rise in these infections can be attributed to various factors, including climate change, increased pet travel, and changes in pet ownership habits. Changing weather patterns and global warming have expanded the geographic ranges of parasites, leading to an increased risk of infections in previously unaffected areas. As people travel more with their pets, they expose their animals to different environments and potentially to new parasites. This increases the risk of parasitic infections. The growing humanization of pets and the trend toward urban living have brought pets into closer contact with potential sources of parasitic infections, such as other animals and environments.

Animal Type Insights

The Companion animals segment is projected to experience rapid growth during the forecast period. Companion animals, or pets, have always held a special place in the hearts and homes of people around the world. The 21st century has seen a significant surge in pet ownership. In many countries, the number of households with pets now exceeds those without. This trend can be attributed to various factors, including changing lifestyles, a greater focus on emotional well-being, and the therapeutic benefits of owning pets. With the growing trend of pet ownership, there is a heightened awareness among pet owners regarding the overall health and well-being of their furry friends. In particular, dermatological issues in pets are becoming increasingly recognized. Skin conditions, allergies, and other dermatological problems in dogs and cats can have a significant impact on their quality of life. As a result, pet owners are increasingly seeking professional veterinary care and specialized dermatology drugs to address these issues effectively.

Regional Insights

North America emerged as the dominant player in the global Veterinary Dermatology Drugs market in 2022, holding the largest market share in terms of value. North America boasts a highly developed veterinary healthcare system, with skilled professionals, cutting-edge technologies, and a strong commitment to animal welfare. This environment encourages pet owners to seek dermatological treatment for their beloved animals, thus boosting the market for veterinary dermatology drugs. The United States and Canada have some of the highest pet ownership rates in the world. The sheer number of pets in these countries creates a massive consumer base for veterinary dermatology drugs, making North America an attractive market for manufacturers.

Key Market Players

Elanco Animal Health Incorporated

Ceva Sante Animale

Vetoquinol

Merck & Co., Inc.

Zoetis Inc.

Virbac

Bimeda, Inc

Vivaldis

Bioiberica S.A.U.

Boehringer Ingelheim International GmbH

Report Scope:

In this report, the Global Veterinary Dermatology Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Dermatology Drugs Market, By Indication:

• Parasitic Infections
• Allergic Infections
• Others

Veterinary Dermatology Drugs Market, By Animal Type:

• Companion Animals
• Livestock Animals

Veterinary Dermatology Drugs Market, By Distribution Channel:

• Hospital Pharmacies
• Retail
• E-commerce

Veterinary Dermatology Drugs Market, By Route of Administration:

• Tropical
• Injectable
• Oral

Veterinary Dermatology Drugs Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Veterinary Dermatology Drugs Market.

Available Customizations:

• Global Veterinary Dermatology Drugs market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Veterinary Dermatology Drugs Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Indication (Parasitic Infections, Allergic Infections, Others)
  • 4.2.2. By Animal Type (Companion Animals, Livestock Animals)
  • 4.2.3. By Distribution Channel (Hospital Pharmacies, Retail, E-commerce)
  • 4.2.4. By Route of Administration (Tropical, Injectable, Oral)
  • 4.2.5. By Region
  • 4.2.6. By Company (2022)
• 4.3. Market Map
  • 4.3.1. By Indication
  • 4.3.2. By Animal Type
  • 4.3.3. By Distribution Channel
  • 4.3.4. By Route of Administration
  • 4.3.5. By Region

5. Asia Pacific Veterinary Dermatology Drugs Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Indication
  • 5.2.2. By Animal Type
  • 5.2.3. By Distribution Channel
  • 5.2.4. By Route of Administration
  • 5.2.5. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Veterinary Dermatology Drugs Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Indication
      • 5.3.1.2.2. By Animal Type
      • 5.3.1.2.3. By Distribution Channel
      • 5.3.1.2.4. By Route of Administration
  • 5.3.2. India Veterinary Dermatology Drugs Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Indication
      • 5.3.2.2.2. By Animal Type
      • 5.3.2.2.3. By Distribution Channel
      • 5.3.2.2.4. By Route of Administration
  • 5.3.3. Australia Veterinary Dermatology Drugs Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Indication
      • 5.3.3.2.2. By Animal Type
      • 5.3.3.2.3. By Distribution Channel
      • 5.3.3.2.4. By Route of Administration
  • 5.3.4. Japan Veterinary Dermatology Drugs Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Indication
      • 5.3.4.2.2. By Animal Type
      • 5.3.4.2.3. By Distribution Channel
      • 5.3.4.2.4. By Route of Administration
  • 5.3.5. South Korea Veterinary Dermatology Drugs Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Indication
      • 5.3.5.2.2. By Animal Type
      • 5.3.5.2.3. By Distribution Channel
      • 5.3.5.2.4. By Route of Administration

6. Europe Veterinary Dermatology Drugs Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Indication
  • 6.2.2. By Animal Type
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Route of Administration
  • 6.2.5. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Veterinary Dermatology Drugs Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Indication
      • 6.3.1.2.2. By Animal Type
      • 6.3.1.2.3. By Distribution Channel
      • 6.3.1.2.4. By Route of Administration
  • 6.3.2. Germany Veterinary Dermatology Drugs Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Indication
      • 6.3.2.2.2. By Animal Type
      • 6.3.2.2.3. By Distribution Channel
      • 6.3.2.2.4. By Route of Administration
  • 6.3.3. Spain Veterinary Dermatology Drugs Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Indication
      • 6.3.3.2.2. By Animal Type
      • 6.3.3.2.3. By Distribution Channel
      • 6.3.3.2.4. By Route of Administration
  • 6.3.4. Italy Veterinary Dermatology Drugs Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Indication
      • 6.3.4.2.2. By Animal Type
      • 6.3.4.2.3. By Distribution Channel
      • 6.3.4.2.4. By Route of Administration
  • 6.3.5. United Kingdom Veterinary Dermatology Drugs Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Indication
      • 6.3.5.2.2. By Animal Type
      • 6.3.5.2.3. By Distribution Channel
      • 6.3.5.2.4. By Route of Administration

7. North America Veterinary Dermatology Drugs Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Indication
  • 7.2.2. By Animal Type
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Route of Administration
  • 7.2.5. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Veterinary Dermatology Drugs Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Indication
      • 7.3.1.2.2. By Animal Type
      • 7.3.1.2.3. By Distribution Channel
      • 7.3.1.2.4. By Route of Administration
  • 7.3.2. Mexico Veterinary Dermatology Drugs Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Indication
      • 7.3.2.2.2. By Animal Type
      • 7.3.2.2.3. By Distribution Channel
      • 7.3.2.2.4. By Route of Administration
  • 7.3.3. Canada Veterinary Dermatology Drugs Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Indication
      • 7.3.3.2.2. By Animal Type
      • 7.3.3.2.3. By Distribution Channel
      • 7.3.3.2.4. By Route of Administration

8. South America Veterinary Dermatology Drugs Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Indication
  • 8.2.2. By Animal Type
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Route of Administration
  • 8.2.5. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Veterinary Dermatology Drugs Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Indication
      • 8.3.1.2.2. By Animal Type
      • 8.3.1.2.3. By Distribution Channel
      • 8.3.1.2.4. By Route of Administration
  • 8.3.2. Argentina Veterinary Dermatology Drugs Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Indication
      • 8.3.2.2.2. By Animal Type
      • 8.3.2.2.3. By Distribution Channel
      • 8.3.2.2.4. By Route of Administration
  • 8.3.3. Colombia Veterinary Dermatology Drugs Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Indication
      • 8.3.3.2.2. By Animal Type
      • 8.3.3.2.3. By Distribution Channel
      • 8.3.3.2.4. By Route of Administration

9. Middle East and Africa Veterinary Dermatology Drugs Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Indication
  • 9.2.2. By Animal Type
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Route of Administration
  • 9.2.5. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Veterinary Dermatology Drugs Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Indication
      • 9.3.1.2.2. By Animal Type
      • 9.3.1.2.3. By Distribution Channel
      • 9.3.1.2.4. By Route of Administration
  • 9.3.2. Saudi Arabia Veterinary Dermatology Drugs Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Indication
      • 9.3.2.2.2. By Animal Type
      • 9.3.2.2.3. By Distribution Channel
      • 9.3.2.2.4. By Route of Administration
  • 9.3.3. UAE Veterinary Dermatology Drugs Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Indication
      • 9.3.3.2.2. By Animal Type
      • 9.3.3.2.3. By Distribution Channel
      • 9.3.3.2.4. By Route of Administration

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Veterinary Dermatology Drugs Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Elanco Animal Health Incorporated
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Product & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Ceva Sante Animale
• 14.3. Vetoquinol
• 14.4. Merck & Co., Inc.
• 14.5. Zoetis Inc.
• 14.6. Virbac
• 14.7. Bimeda, Inc
• 14.8. Vivaldis
• 14.9. Bioiberica S.A.U.
• 14.10. Boehringer Ingelheim International GmbH

15. Strategic Recommendations

16. About Us & Disclaimer